Page last updated: 2024-12-07

taraxerol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Taraxerol is a pentacyclic triterpene found in various plants, including dandelion (Taraxacum officinale). It exhibits diverse pharmacological activities, including anti-inflammatory, antioxidant, anticancer, and hepatoprotective properties. Research focuses on understanding its potential therapeutic applications in various diseases. Synthesis of taraxerol involves complex multi-step reactions, but its natural abundance makes extraction a viable option. Studies on taraxerol explore its mechanisms of action, such as its ability to modulate signaling pathways and interact with specific molecular targets. Its potential to combat inflammation and oxidative stress has garnered considerable attention. Taraxerol's safety profile is being investigated, but preliminary studies suggest a low risk of adverse effects. Further research is needed to elucidate its therapeutic potential and optimize its use.'

taraxerol: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

taraxerol : A pentacyclic triterpenoid that is oleanan-3-ol lacking the methyl group at position 14, with an alpha-methyl substituent at position 13 and a double bond between positions 14 and 15. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID92097
CHEMBL ID511822
CHEBI ID9402
SCHEMBL ID569463
MeSH IDM0047567

Synonyms (35)

Synonym
alnulin
C08637
127-22-0
taraxerol
d-friedoolean-14-en-3beta-ol
bdbm50242128
CHEMBL511822 ,
chebi:9402 ,
(3s,4ar,6ar,6as,8ar,12ar,14ar,14br)-4,4,6a,6a,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-ol
skimmiol
(3beta)-d-friedoolean-14-en-3-ol
tiliadin
(3s,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4,4a,5,6,6a,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-icosahydropicen-3-ol
a32778o852 ,
unii-a32778o852
d-friedoolean-14-en-3-ol, (3beta)-
(3.beta.)-d-friedoolean-14-en-3-ol
taraxerol [mi]
isoolean-14-en-3.beta.-ol
27-norolean-14-en-3-ol, 13-methyl-, (3.beta.,13.alpha.)-
SCHEMBL569463
3beta-taraxerol, analytical standard
A889278
3beta-taraxerol
AKOS032962064
HY-N2477
mfcd13186859
CS-0022748
27-norolean-14-en-3-ol, 13-methyl-, (3beta,13alpha)-
XT176542
27-norolean-14-en-3-ol,13-methyl-, (3b,13a)-
DTXSID001026552
AS-80186
isoolean-14-en-3beta-ol
d-friedoolean-14-en-3 beta-ol

Research Excerpts

Overview

Taraxerol (TRX) is a triterpene that has been isolated from several plant species. Its various pharmacological properties have already been identified. It has good effects on the treatment of inflammation and tumors.

ExcerptReferenceRelevance
"Taraxerol is an oleanane-type pentacyclic triterpenoid compound distributed in many plant species that has good effects on the treatment of inflammation and tumors. "( Heterologous biosynthesis of taraxerol by engineered Saccharomyces cerevisiae.
Lu, W; Pai, H; Tan, J; Zhang, C, 2022
)
2.46
"Taraxerol (TRX) is a triterpene that has been isolated from several plant species, and its various pharmacological properties have already been identified, such the acetylcholinesterase (AChE) inhibition activity in vitro."( Taraxerol as a possible therapeutic agent on memory impairments and Alzheimer's disease: Effects against scopolamine and streptozotocin-induced cognitive dysfunctions.
Berté, TE; Bürger, C; Cechinel-Filho, V; Dalmagro, AP; de Souza, MM; Dos Santos, DA; Gonçalves, AE; Meyre-Silva, C; Weber, CJ; Zimath, PL, 2018
)
2.64

Effects

ExcerptReferenceRelevance
"Taraxerol has inhibitory effects on AGS cell growth through inducing G(2)/M arrest and promotion of cell apoptosis. "( [Effects of taraxerol and taraxerol acetate on cell cycle and apoptosis of human gastric epithelial cell line AGS].
Ji, G; Shi, HL; Tan, B; Xie, JQ, 2011
)
2.19

Treatment

ExcerptReferenceRelevance
"Taraxerol (10mg/kg) treatment could significantly (p<0.01) attenuate carrageenan mediated up-regulation in the levels of IL 1β, IL 6, IL 12 and TNF α in the right paw tissues."( Taraxerol, a pentacyclic triterpene from Abroma augusta leaf, attenuates acute inflammation via inhibition of NF-κB signaling.
Bhattacharjee, N; Dewanjee, S; Dua, TK; Khanra, R, 2017
)
2.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
pentacyclic triterpenoid
secondary alcoholA secondary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has two other carbon atoms attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
pentacyclic triterpene biosynthesis1411
mangrove triterpenoid biosynthesis77

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Nitric oxide synthase, inducibleMus musculus (house mouse)IC50 (µMol)24.20000.00103.39119.6000AID344829
Ghrelin O-acyltransferaseHomo sapiens (human)IC50 (µMol)100.00006.00007.50008.0000AID1802486
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (3)

Processvia Protein(s)Taxonomy
peptide hormone processingGhrelin O-acyltransferaseHomo sapiens (human)
peptidyl-serine octanoylationGhrelin O-acyltransferaseHomo sapiens (human)
lipid modificationGhrelin O-acyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
O-acyltransferase activityGhrelin O-acyltransferaseHomo sapiens (human)
acyltransferase activity, transferring groups other than amino-acyl groupsGhrelin O-acyltransferaseHomo sapiens (human)
serine O-acyltransferase activityGhrelin O-acyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
endoplasmic reticulumGhrelin O-acyltransferaseHomo sapiens (human)
endoplasmic reticulum membraneGhrelin O-acyltransferaseHomo sapiens (human)
endoplasmic reticulum membraneGhrelin O-acyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (20)

Assay IDTitleYearJournalArticle
AID360633Inhibition of human K562 cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting2001Journal of natural products, May, Volume: 64, Issue:5
Cytotoxic principles from Ventilago leiocarpa.
AID671762Inhibition of HCV NS3 helicase overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of DNA unwinding activity at 10 uM by FRET assay2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID360626Inhibition of human HeLa cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting2001Journal of natural products, May, Volume: 64, Issue:5
Cytotoxic principles from Ventilago leiocarpa.
AID360640Inhibition of human Raji cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting2001Journal of natural products, May, Volume: 64, Issue:5
Cytotoxic principles from Ventilago leiocarpa.
AID333687Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2004Journal of natural products, Dec, Volume: 67, Issue:12
New furofuran and butyrolactone lignans with antioxidant activity from the stem bark of Styrax japonica.
AID402278Cytotoxicity against human A2780 cells2004Journal of natural products, May, Volume: 67, Issue:5
New cytotoxic terpenoids from the wood of Vepris punctata from the Madagascar Rainforest.
AID360647Inhibition of african green monkey Vero cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting2001Journal of natural products, May, Volume: 64, Issue:5
Cytotoxic principles from Ventilago leiocarpa.
AID597077Antiparasitic activity against Trypanosoma brucei rhodesiense STIB 900 bloodstream form after 72 hrs by microplate fluorimetry2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiparasitic compounds from Cupania cinerea with activities against Plasmodium falciparum and Trypanosoma brucei rhodesiense.
AID671764Inhibition of HCV NS3 helicase ATP hydrolysis activity overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of inorganic phosphate release by AM/MG-based colometric analysis in the presence of M13 ssDNA2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID597078Cytotoxicity against rat L6 cells after 72 hrs by microplate fluorimetry2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiparasitic compounds from Cupania cinerea with activities against Plasmodium falciparum and Trypanosoma brucei rhodesiense.
AID1256912Inhibition of human IDH1 R132H mutant expressed in IPTG-induced Escherichia coli BL21 cells assessed as oxidation of NADPH to NADP+ after 5 mins by spectrophotometry2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
AID597076Antiplasmodial activity against chloroquine- and pyrimethamine-resistant Plasmodium falciparum K1 infected in human red blood cells assessed as [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counting2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiparasitic compounds from Cupania cinerea with activities against Plasmodium falciparum and Trypanosoma brucei rhodesiense.
AID344828Inhibition of NADPH oxidase in LPS-induced mouse BV2 cells assessed as NOX-dependent ROS production at 50 uM2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
New diterpenoids and the bioactivity of Erythrophleum fordii.
AID1256913Inhibition of human IDH1 expressed in IPTG-induced Escherichia coli BL21 cells assessed as reduction of NADP+ to NADPH after 5 mins by spectrophotometry2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
AID671763Inhibition of SARS coronavirus nsP13 ATP hydrolysis activity expressed in Escherichia coli Rosetta assessed as inhibition of inorganic phosphate release at 10 uM by AM/MG-based colometric analysis in the presence of M13 ssDNA2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID360654Inhibition of human WISH cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting2001Journal of natural products, May, Volume: 64, Issue:5
Cytotoxic principles from Ventilago leiocarpa.
AID360618Inhibition of human Calu1 cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting2001Journal of natural products, May, Volume: 64, Issue:5
Cytotoxic principles from Ventilago leiocarpa.
AID671761Inhibition of SARS coronavirus nsP13 helicase activity expressed in Escherichia coli Rosetta assessed inhibition of DNA unwinding activity at 10 uM by FRET assay2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID344829Inhibition of iNOS-mediated NO production in LPS-induced mouse BV2 cells2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
New diterpenoids and the bioactivity of Erythrophleum fordii.
AID1802486GOAT Activity Assay from Article 10.1021/acs.biochem.6b01008: \\Synthetic Triterpenoid Inhibition of Human Ghrelin O-Acyltransferase: The Involvement of a Functionally Required Cysteine Provides Mechanistic Insight into Ghrelin Acylation.\\2017Biochemistry, 02-21, Volume: 56, Issue:7
Synthetic Triterpenoid Inhibition of Human Ghrelin O-Acyltransferase: The Involvement of a Functionally Required Cysteine Provides Mechanistic Insight into Ghrelin Acylation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (62)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (3.23)18.7374
1990's5 (8.06)18.2507
2000's20 (32.26)29.6817
2010's28 (45.16)24.3611
2020's7 (11.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.15 (24.57)
Research Supply Index4.20 (2.92)
Research Growth Index5.19 (4.65)
Search Engine Demand Index43.69 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other66 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]